表紙:歩行補助器具の世界市場:種類別(ケイン、松葉杖、歩行補助車、歩行器)の市場調査、予測(~2026年)、COVID-19の累積的な影響
市場調査レポート
商品コード
1001107

歩行補助器具の世界市場:種類別(ケイン、松葉杖、歩行補助車、歩行器)の市場調査、予測(~2026年)、COVID-19の累積的な影響

Walking Aids Market Research Report by Type (Cane, Crutch, and Rollator), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
歩行補助器具の世界市場:種類別(ケイン、松葉杖、歩行補助車、歩行器)の市場調査、予測(~2026年)、COVID-19の累積的な影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の歩行補助器具の市場規模は、2020年の21億6,268万米ドルから、2025年末までに30億2,251万米ドルに成長すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた比類のない世界的な公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されます。私たちの進行中の調査は、調査フレームワークを増幅して、基礎となるCOVID-19の問題と今後の潜在的な道筋を確実に含めるようにしています。調査は消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場の力のダイナミクス、および政府の重要な介入を考慮した、COVID-19に関する洞察を提供しています。更新された調査は、市場へのCOVID-19の影響を考慮して、洞察、分析、推定、および予測を提供します。

 

当レポートでは歩行補助器具の世界市場を調査し、市場の概要、市場の成長要因および阻害要因の分析、市場機会、COVID-19の影響、種類別・地域別の市場規模の推移と予測、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査のために考慮された年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画の作成
    • 実行:調査の実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • 市場の見通し
  • 種類の見通し
  • 地域の見通し
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズのファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 種類別

  • ケイン
    • 多足杖
    • シングルケイン
  • 松葉杖
    • 腋窩または脇の下の松葉杖
    • 前腕松葉杖
    • ガター松葉杖
  • 歩行補助車
  • 歩行器

第7章 南北アメリカ

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第8章 アジア太平洋地域

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第9章 欧州、中東・アフリカ

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第10章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第11章 企業のユーザビリティプロファイル

  • 21st century scientific Inc
  • Amigo Mobility International Inc.
  • Benmor Medical
  • Briggs Healthcare
  • Carex Health Brands
  • Eurovema Mobility AB
  • Evolution Technologies Inc.
  • GF Health Products, Inc.
  • Hill-Rom Holdings Inc
  • HUMAN CARE GROUP
  • Invacare Corporation
  • Karman Healthcare Inc
  • MATSUNAGA MANUFACTORY Co., Ltd.
  • Medical Depot, Inc.
  • MEYRA GmbH
  • Otto Bock Australia Pty. Ltd.
  • Patterson Medical Holdings Inc.
  • Permobil
  • Pride mobility products corp
  • Stryker Corporation
  • Sunrise Medical, Inc.
  • Topro Industrie AS

第12章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL WALKING AIDS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL WALKING AIDS MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL WALKING AIDS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2026
  • FIGURE 9. GLOBAL WALKING AIDS MARKET SIZE, BY CANE, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL WALKING AIDS MARKET SIZE, BY CANE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL WALKING AIDS MARKET SIZE, BY MULTIPLE-LEGGED CANE, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL WALKING AIDS MARKET SIZE, BY MULTIPLE-LEGGED CANE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL WALKING AIDS MARKET SIZE, BY SINGLE CANE, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL WALKING AIDS MARKET SIZE, BY SINGLE CANE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL WALKING AIDS MARKET SIZE, BY CRUTCH, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL WALKING AIDS MARKET SIZE, BY CRUTCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL WALKING AIDS MARKET SIZE, BY AXILLA OR UNDERARM CRUTCH, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL WALKING AIDS MARKET SIZE, BY AXILLA OR UNDERARM CRUTCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. GLOBAL WALKING AIDS MARKET SIZE, BY FOREARM CRUTCH, 2018-2026 (USD MILLION)
  • FIGURE 20. GLOBAL WALKING AIDS MARKET SIZE, BY FOREARM CRUTCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. GLOBAL WALKING AIDS MARKET SIZE, BY GUTTER CRUTCH, 2018-2026 (USD MILLION)
  • FIGURE 22. GLOBAL WALKING AIDS MARKET SIZE, BY GUTTER CRUTCH, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 23. GLOBAL WALKING AIDS MARKET SIZE, BY ROLLATOR, 2018-2026 (USD MILLION)
  • FIGURE 24. GLOBAL WALKING AIDS MARKET SIZE, BY ROLLATOR, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 25. GLOBAL WALKING AIDS MARKET SIZE, BY WALKER, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL WALKING AIDS MARKET SIZE, BY WALKER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. AMERICAS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 28. AMERICAS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 30. ARGENTINA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. BRAZIL WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. CANADA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. MEXICO WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. UNITED STATES WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. CALIFORNIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. FLORIDA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. ILLINOIS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. NEW YORK WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. OHIO WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. PENNSYLVANIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. TEXAS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 43. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 45. CHINA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. INDIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. INDONESIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. JAPAN WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. MALAYSIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PHILIPPINES WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. SOUTH KOREA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. THAILAND WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 56. FRANCE WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. GERMANY WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. ITALY WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. NETHERLANDS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. QATAR WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. RUSSIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. SPAIN WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GLOBAL WALKING AIDS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 68. GLOBAL WALKING AIDS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 69. GLOBAL WALKING AIDS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 70. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL WALKING AIDS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL WALKING AIDS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL WALKING AIDS MARKET SIZE, BY CANE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL WALKING AIDS MARKET SIZE, BY MULTIPLE-LEGGED CANE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL WALKING AIDS MARKET SIZE, BY SINGLE CANE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL WALKING AIDS MARKET SIZE, BY CRUTCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL WALKING AIDS MARKET SIZE, BY AXILLA OR UNDERARM CRUTCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL WALKING AIDS MARKET SIZE, BY FOREARM CRUTCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL WALKING AIDS MARKET SIZE, BY GUTTER CRUTCH, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL WALKING AIDS MARKET SIZE, BY ROLLATOR, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL WALKING AIDS MARKET SIZE, BY WALKER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. ARGENTINA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. BRAZIL WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. MEXICO WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. UNITED STATES WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. UNITED STATES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. CALIFORNIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. FLORIDA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ILLINOIS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. NEW YORK WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. OHIO WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. PENNSYLVANIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. TEXAS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. ASIA-PACIFIC WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. CHINA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. INDIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. INDONESIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. JAPAN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MALAYSIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. PHILIPPINES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. SOUTH KOREA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. THAILAND WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FRANCE WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. GERMANY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ITALY WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. NETHERLANDS WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. QATAR WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. RUSSIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. SAUDI ARABIA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. SOUTH AFRICA WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. SPAIN WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. UNITED ARAB EMIRATES WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. UNITED KINGDOM WALKING AIDS MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. GLOBAL WALKING AIDS MARKET: SCORES
  • TABLE 52. GLOBAL WALKING AIDS MARKET: BUSINESS STRATEGY
  • TABLE 53. GLOBAL WALKING AIDS MARKET: PRODUCT SATISFACTION
  • TABLE 54. GLOBAL WALKING AIDS MARKET: RANKING
  • TABLE 55. GLOBAL WALKING AIDS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 56. GLOBAL WALKING AIDS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 57. GLOBAL WALKING AIDS MARKET: MERGER & ACQUISITION
  • TABLE 58. GLOBAL WALKING AIDS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 59. GLOBAL WALKING AIDS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 60. GLOBAL WALKING AIDS MARKET: INVESTMENT & FUNDING
  • TABLE 61. GLOBAL WALKING AIDS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 62. GLOBAL WALKING AIDS MARKET: LICENSE & PRICING
  • TABLE 63. GLOBAL WALKING AIDS MARKET: CONTACT DETAILS
目次
Product Code: MRR-436145BF8BE6

The Global Walking Aids Market size was estimated at USD 2,162.68 Million in 2020 and expected to reach USD 2,323.23 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.76% to reach USD 3,386.84 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Walking Aids to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Walking Aids Market was studied across Cane, Crutch, Rollator, and Walker. The Cane is further studied across Multiple-legged Cane and Single Cane. The Crutch is further studied across Axilla or Underarm Crutch, Forearm Crutch, and Gutter Crutch.

Based on Geography, the Walking Aids Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Walking Aids Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Walking Aids Market, including 21st century scientific Inc, Amigo Mobility International Inc., Benmor Medical, Briggs Healthcare, Carex Health Brands, Eurovema Mobility AB, Evolution Technologies Inc., GF Health Products, Inc., Hill-Rom Holdings Inc, HUMAN CARE GROUP, Invacare Corporation, Karman Healthcare Inc, MATSUNAGA MANUFACTORY Co., Ltd., Medical Depot, Inc., MEYRA GmbH, Otto Bock Australia Pty. Ltd., Patterson Medical Holdings Inc., Permobil, Pride mobility products corp, Stryker Corporation, Sunrise Medical, Inc., and Topro Industrie AS.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Walking Aids Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Walking Aids Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Walking Aids Market?
  • 4. What is the competitive strategic window for opportunities in the Global Walking Aids Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Walking Aids Market?
  • 6. What is the market share of the leading vendors in the Global Walking Aids Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Walking Aids Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Type Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly population and rise in obesity among population
      • 5.1.1.2. Rising incidence of arthritis and Parkinson's disease
      • 5.1.1.3. Favorable government policies and regulations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the product
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust technological advancements with customization of walking aids
      • 5.1.3.2. Emerging research and development activities to improvise the product
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of low quality products in the market
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Walking Aids Market, by Type

  • 6.1. Introduction
  • 6.2. Cane
    • 6.2.1. Multiple-legged Cane
    • 6.2.2. Single Cane
  • 6.3. Crutch
    • 6.3.1. Axilla or Underarm Crutch
    • 6.3.2. Forearm Crutch
    • 6.3.3. Gutter Crutch
  • 6.4. Rollator
  • 6.5. Walker

7. Americas Walking Aids Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Walking Aids Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Walking Aids Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. 21st century scientific Inc
  • 11.2. Amigo Mobility International Inc.
  • 11.3. Benmor Medical
  • 11.4. Briggs Healthcare
  • 11.5. Carex Health Brands
  • 11.6. Eurovema Mobility AB
  • 11.7. Evolution Technologies Inc.
  • 11.8. GF Health Products, Inc.
  • 11.9. Hill-Rom Holdings Inc
  • 11.10. HUMAN CARE GROUP
  • 11.11. Invacare Corporation
  • 11.12. Karman Healthcare Inc
  • 11.13. MATSUNAGA MANUFACTORY Co., Ltd.
  • 11.14. Medical Depot, Inc.
  • 11.15. MEYRA GmbH
  • 11.16. Otto Bock Australia Pty. Ltd.
  • 11.17. Patterson Medical Holdings Inc.
  • 11.18. Permobil
  • 11.19. Pride mobility products corp
  • 11.20. Stryker Corporation
  • 11.21. Sunrise Medical, Inc.
  • 11.22. Topro Industrie AS

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details